Ponies (individuals with a wither height less than 58 in.) are more insulin insensitive then large breed horses, 3 and metabolic comparisons across breeds have consistently found ponies to be among the more insulin-resistant groups. 4, 5 Unlike many large breed horses, after domestication ponies have maintained a metabolically thrifty phenotype with seasonally adaptive changes including suppressed metabolic rates and excessive fat storage. 6 However, the mechanisms underlying ponies' unique metabolic profiles and greater EMS susceptibility have not been identified.
A relationship between individuals of short stature and an increased risk of chronic disease has been well described in humans. [7] [8] [9] In particular, there are significant associations between height and the risk of developing Type 2 diabetes or metabolic syndrome (MetS), [10] [11] [12] [13] [14] [15] with measured metabolic abnormalities more severe in shorter individuals. 10, 11, 16, 17 Many negative correlations between height and specific derangements of the endocrine system include: obesity, 16, 18, 19 regional adiposity, 14 elevated triglycerides, 11, 20 impaired glucose tolerance post oral sugar test (OST), 17, 21 and insulin resistance. [10] [11] [12] 16 Several underlying mechanisms for these associations have been proposed, including a poor uterine environment, impaired nutrition, adverse social circumstances, and genetic factors. 10, [22] [23] [24] [25] The role of genetic factors is supported by the identification of pleiotropic effect between variants within the promoter of the GAD2 gene and low birth weight, decreased length, impaired insulin secretion, and early onset obesity, 26 as well as associations between single nucleotide polymorphisms (SNPs) in the LMNA gene with short stature and elevated triglycerides, and obesity and increased waist circumference. 27 We hypothesize that loci affecting height could also have pleiotropic effects on metabolic pathways in horses and ponies and increase the risk for EMS. Here we use genomic tools to identify a chromosomal locus associated with both height and fasting insulin concentrations in Welsh ponies and demonstrate that a probable functional mutation in the high mobility group AT-hook 2 (HMGA2) gene is contributing to both height and metabolic traits.
| MATERIALS AND METHODS

| Samples
Two hundred ninety-four Welsh ponies (213 females and 81 males) from 32 farms within the United States were included in the study, with ages ranging from 2 to 33 years (mean age of 11.7 years). As a breed, Welsh ponies are divided into 6 sections based on pedigree and height (see Supporting Information Table 1 ), which were represented in our cohort as follows: section A (n = 74), section B
(n = 146), section C (n = 3), section D (n = 15), section H (n = 26), and unregistered Welsh ponies (n = 10). A total of 529 individuals from 4 large-breed horses, Quarter horses (n = 59), Arabians (n = 64),
Tennessee Walking Horses (n = 48), and Morgan horses (n = 293), as well as 65 horses of other pure or mixed breeds, were also collected.
These samples were obtained from farms throughout North America and represented 300 females and 229 males with an age range of 2-33 years old (mean age of 13 years).
| Phenotype data
Signalment, medical history, height at the withers, and biochemical measurements at baseline and after an OST were collected on all indi- Quality control (QC) measures were performed on the genotyping data using the PLINK software package. 31 This included SNP and individual missingness and genotyping rates, discordant sex information, and abnormally high heterozygosity (≥3 SDs from the mean). All individuals passed QC and were kept in the study cohort. Individual SNPs with a genotyping success rate <90%, minor allele frequency <1.0%, or outside Hardy Weinberg equilibrium were pruned, leaving a total of 1 511 302 SNPs for subsequent analysis.
| F ST -based statistic
Genomic regions of breed-specific population differentiation were identified in the Welsh ponies using SNP data from the 44 individuals genotyped on the MCEc2M. Calculation of the d i statistic was performed using nonoverlapping 10 kilobase (kb) windows across the 31 equine autosomes with a custom Python script (https://github. com/schae234/PonyTools) based on work previously described. 32, 33 The d i statistic detects locus-specific deviation in allele frequencies for the test population relative to the genome-wide average of pairwise F ST summed across populations. The background population contained 463 individuals from 16 different breeds (Supporting Information Table S2 ). Significant d i windows were those corresponding to the top 0.1% of the empirical distribution and were considered regions of interest (ROIs) for putative signatures of selection. Two or more contiguous significant d i windows were considered as a single ROI.
| Association analysis
Association analysis for equine chromosome 6 (ECA6; total of 56 246
SNPs) was performed using imputed SNP genotype data from 
| Haplotype analysis
Local haplotype sharing within the Welsh ponies used for association analysis (n = 264) was calculated from the hapQTL program (http:// www.haplotype.org) with default settings. 42 This approach relies on a statistical model for LD to infer ancestral haplotypes and their frequencies at each SNP marker for individuals within a population. 
| HMGA2 and IRAK3 reconstruction and sequencing
PCR primers were designed for all exons within 2 candidate genes, HMGA2 and interleukin 2 receptor associated kinase 3 (IRAK3), using the Primer3 software. 43 Genomic sequences for primer design were retrieved using the National Center for Biotechnology Information Sequencing results were then analyzed, processed, and aligned using the Sequencher software version 5.1 (Gene Codes Corporation, Ann
Arbor, Michigan).
| HMGA2 exon 1 variant genotyping
Two methods were employed to genotype the HMGA2 exon 1 mutation (c.83G>A) identified by Frischknecht et al. 44 In the first method, standard PCR primers were designed to flank and Sanger sequence this exon (Supporting Information Methods for a full description of this assay). Genotypes for this variant using the second genotyping assay were obtained for an additional 144 Welsh ponies and 241 large breed horses.
| Statistical analyses
Statistics were performed using functions within the software package R. 46 Metabolic traits were tested for normality using a normal probability plot and a Shapiro test; traits were log or square root transformed when appropriate. Correlations between height and EMS traits (insulin, INS-OST, glucose, GLU-OST, NEFA, triglycerides, leptin, adiponectin) and ACTH were calculated using a Pearson's correlation coefficient. After adjusting for multiple testing using a Bonferroni correction (0.05/9), a P-value of <.005 was considered significant.
Analyses were performed as follows: all horses (n = 824), Welsh ponies (n = 294), all large breed horses (n = 529), Quarter horses (n = 59), Arabian horses (n = 64), Morgan horses (n = 293), and Tennessee Walking horses (n = 48). Correlations among genotype for the HMGA2 c83G>A variant and EMS traits, ACTH, or height were calculated for the Welsh ponies (n = 294) using Pearson's correlation coefficient and a Bonferroni-corrected P-value (0.05/10; <.005).
Least-square means were calculated with EMS traits, ACTH, or height as the outcome variable, genotype as the response variable, and age and sex as predictors. The R statistical software package Linear and Nonlinear Mixed Effects Models (nlme) 47 fit the linear model using generalized least squares. The R statistical software package Least-Square Means (lsmeans) 48 was used to calculate the predicted marginal means and pair-wise comparisons.
Model comparison for modes of inheritance between the HMGA2
c.83G>A variant and traits were performed using an analysis of variance (ANOVA) for an additive, dominant, and recessive model.
The P-values of the F-statistic were compared across all 3 models.
The R statistical software package SNPassoc 49 was used to calculate the Akaike information criterion (AIC) and P-value among additive, recessive, dominant, and codominant models. Model selection was based on the lowest AIC values; however, models with less than 10 unit difference between them were considered indistinguishable.
3 | RESULTS
| Correlations among height, EMS traits, and ACTH
Correlation analyses between height and biochemical traits in the entire cohort (n = 823) revealed statistically significant inverse correlations for insulin (−0.12), glucose (−0.11), adiponectin (−0.23), and ACTH (−0.12), whereas positive correlations with height were found for triglycerides (0.14) and leptin (0.12) ( Table 1) . No statistically significant correlations between any of the traits and height were identified in the large breed horses as a whole (n = 529) or within any individual breed (Table 1) . However, within the Welsh pony population (n = 294), a statistically significant inverse correlation with height was identified for insulin (−0.26), with the correlation coefficient between height and insulin higher than in the entire population ( Table 1 ), indicating that the pony population was predominately driving the association observed for this trait in the full cohort. 
| Association analysis
For the Welsh pony cohort, P-values for 142 SNPs on ECA6 associated with height exceeded the threshold for genome-wide significance (Figure 2A ). Based on EquCab2, all 142 SNPs were within the samẽ the entire analysis (maximum BF of 7.5). HapQTL did not identify haplotypes on ECA6 for any of the other traits.
| Candidate gene identification, sequencing, and genotyping
The ROI identified in our study from association analysis and d i statis- Table 5 ). Table 5 ). Pairwise comparisons between the marginal means and genotype for NEFA also revealed statistically significant differences between the A/A and G/A genotypes ( Figure 4E ).
| DISCUSSION
It is well recognized that ponies are at high risk for developing EMS;
however, the mechanisms underlying this increased susceptibility, and the roles that genetic factors might play, are not understood. In our study, we demonstrated that baseline insulin values, a major component of the EMS phenotype, were correlated to height in Welsh ponies. With complementary genome-wide analysis methods with high-density SNP genotype data, we identified and fine-mapped a locus on ECA6 associated with both of these traits in Welsh ponies, which we estimated to be contributing~40% and~20% of the total High-density SNP genotype data enabled us to use an F ST -based approach (di) to detect regions of low heterogeneity that exist because of selection for a phenotype, as well as identify genomic regions containing variants associated with both height and insulin on ECA6. We identified several breed-specific loci undergoing selection in the Welsh pony; however, the region with the highest number of significant di windows, as well as those at the top of the empirical distribution, was a~782 kb segment on ECA6 that was within the boundaries of the 1.3 Mb ROI identified by association analysis. Although the di statistic is blinded to phenotype, given the extensive breeding selection for short stature in ponies and the overlapping results with the association analysis, we surmised that selection for height was responsible for this genomic signature. Based on our cohort and the high heritability of height and baseline insulin, our association analysis had adequate power to identify alleles with moderate to high effect size 51 and readily detected the ECA6 locus in Welsh ponies for both traits.
With genomic partitioning, we estimated that the ROI (ECA6:
80 499 826 to 81 809 066) contributed to 39% of the genetic variation for height and 24% for baseline insulin. However, this approach leads to inclusion of SNPs that were top predictors from association analysis, violating the effect size assumption when using a restricted estimated maximum likelihood analysis. Thus, we also performed a We identified a haplotype block that spanned the entire height ROI on ECA6 found by association analysis, while haplotype blocks in the same region for baseline insulin contained distinct major and minor peaks. This likely reflects differences in variant effect size, nonshared factors affecting the traits, and selection for height. We showed that 39%-47% of the genetic variance in height could be explained by our ROI on ECA6; thus, the locus has a large effect on height in ponies. In contrast, the effect on insulin is smaller at 21%-25% of the genetic variation. This is consistent with the results from the Pearson's correlation between height and insulin, which was −0.26, indicating that not all the variation in insulin could be explained by its relationship to height with nonshared factors present between , whereas, gain-of-function mutations of this gene led to gigantism, excessive fat formation, and lipomatosis in both mice and humans. 63, 64 In addition to the alterations in fat metabolism noted above, HMGA2 has been associated with other causes of metabolic derangements, particularly type II diabetes in humans. 65 Voight et al. hypothesized that an HMGA2 variant was likely affecting insulin levels independent of an obesity-driven mechanism. 65 Since then, both genome-wide association and meta-analyses have replicated this result. [66] [67] [68] The only HMGA2 variant found in our panel of 48 horses was a missense mutation (c.83G>A) in exon 1, which was previously described as associated with decreased height in Shetland and other pony breeds. 44 The variant, with its glycine to glutamate substitution at residue 28, is predicted to affect the first AT hook, and the authors demonstrated that the mutant nucleotide sequence had decreased binding affinity for DNA. This is additional evidence supporting the likely functional impact of this mutation.
In our pony cohort, the HMGA2 variant had an allele frequency of 0.76, was distributed across the sections of the Welsh pony breed consistent with their height distribution, was negatively correlated (−0.75) with height, and its effect was explained by an additive model of inheritance in our population of ponies. We also identified a negative correlation for the A allele with 4 EMS traits, including insulin, NEFA, INS-OST, and triglycerides. This provides evidence that HMGA2 is having an effect on EMS traits beyond modulating height.
Notably, pairwise comparisons of NEFA between genotypes revealed that, although there was a statistical difference between the A/A and G/A genotypes, there was not a difference between either of the homozygous genotypes. This is most likely due to the large 95% confidence intervals identified when assessing the least square means for genotype and NEFA concentrations in the ponies, particularly those with the G/G genotype ( Figure 4E ). Pairwise comparisons between the least squared means for genotype and insulin, INS-OST, and triglycerides suggested a recessive model of inheritance; however, model analyses were unable to differentiate between an additive or recessive model. The lack of distinction is likely because of the large variation within EMS traits, as well as bias owing to unequal sampling among our ponies, as our cohort only included 3 section Cs and 15 section Ds. Therefore, inclusion of more samples from these sections would likely improve our power to differentiate between an additive and recessive model.
IRAK3 was included as a biological candidate gene due to evidence in other species and its close proximity to the fine mapped ROI. IRAK3 is downregulated in individuals with obesity and metabolic syndrome and is believed to be a key inhibitor of inflammation during metabolic derangements. 69 Furthermore, IRAK3 mutant mouse phenotypes include reduced body size, decreased femur diameter, and abnormal bone morphology, 70 as well as impaired glucose tolerance. 71 We sequenced the IRAK3 gene in our sample panel of horses but did not find any variants. Although a predicted miRNA (MIR763) was within our refined ROI, its function is unknown and does not have any associated orthologues.
In conclusion, through genome-wide analyses, we identified an allele for a known height gene, HMGA2, as contributing to both height and several EMS traits in a cohort of Welsh ponies. Additional functional analysis would determine if the HMGA2 mutation has a pleiotropic effect on these traits or if another unidentified variant within our ROI independently contributes to the EMS traits and has been inadvertently selected for due to genomic hitchhiking. Although our study focused on Welsh ponies, the HMGA2 variant has been correlated with height in other pony breeds; thus, it is likely that this variant is also having an effect on metabolic traits in these individuals, as supported by the correlation analysis with the addition of 3 Shetland, 2 Hackney, and 3 British Riding ponies to our cohort (Supporting Information Table 7 ). Moreover, although height was not correlated with EMS traits in the large breed horses in our study, this does not rule out stature as contributing to these traits in that population. In humans, leg-length-to-torso ratios are consistently correlated with metabolic traits over total height. 11 Therefore, length-to-torso ratios in large breed horses might reveal a correlation not identified in this analysis. These data are a major step forward towards understanding genetic influences on EMS that could also have implications for improving equine health and understanding contributors to MetS. 
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